Search results for:vaccine

Need a new search?

If you didn't find what you were looking for, try a new search!

Results from trials of vaccines remain unreported

The results of clinical trials of vaccines involving 11,527 people remain unreported and unused according to a recent study in The BMJ. Researchers looked at 384 vaccine trials registered in at least one of several clinical trial registers between 2006 and 2012. They found that trials took an average of 26 months after ending to […]

10th July 2014|

Oxford Vaccine Group

16th April 2014|

Unreported Clinical Trial of the Week

The AllTrials campaign is shining a spotlight on clinical trials that haven’t published results, one per week from now on in the BMJ. Read more about this new series in the BMJ.

The trials we write about will be one of those flagged by the FDAAA Compliance Tracker and, as of 14 September 2018, the EU TrialsTracker […]

29th March 2018|

“No more excuses” as major global research funders take strong lead on clinical trial transparency

Some of the world’s largest research funders and NGOs today agreed to adopt the WHO’s strong standards on clinical trial transparency. This means all clinical trials they fund or support will be registered and the results reported.

In a joint statement, nine major funders including Médecins Sans Frontières, the Bill & Melinda Gates Foundation, the Indian Council of Medical […]

17th May 2017|

European Medicines Agency today releases first Clinical Study Reports

Today, the European Medicines Agency for the first time ever proactively releases key documents that will allow independent researchers to verify pharmaceutical companies’ claims about the safety and effectiveness of new medicines. Clinical Study Reports, as the documents are called, provide detailed information on the methodologies and results of clinical trials. Today’s release represents a […]

20th October 2016|

Companies ranked by drug trial transparency

A new study published in BMJ Open found that for 15 drugs approved by the US Food and Drug Administration (FDA) in 2012, a median 57% of clinical trials were registered, and only 65% of trial results were publicly available. Almost half of the drugs had at least one undisclosed phase II or III trial. […]

17th November 2015|

UK Government cites AllTrials in G7 transparency pledge

The Department of Health has told us more detail behind UK Prime Minister David Cameron’s comments at G7, on the need for trials transparency in public health emergencies.

The new commitment is that whenever a UK Government body funds or co-funds research or work into diseases that are a threat to global health security, that work will […]

11th June 2015|

Prime Minister calls for G7 agreement on clinical trial transparency

To combat the outbreak and spread of deadly viruses like Ebola, UK Prime Minister David Cameron is urging G7 leaders to develop an international agreement to require all clinical trials to be published. The recent Ebola outbreak showed that when data on disease outbreaks is not shared quickly, the disease can get out of control. […]

8th June 2015|

Liverpool School of Tropical Medicine

Liverpool School of Tropical Medicine (LSTM) is committed to the principle of open and accessible research, so fully supports and is committed to the principles of the AllTrials Campaign. LSTM endorses the principle of having all clinical research registered and the results of such studies published as quickly as possible following their completion (in line […]

17th November 2014|

ABPI research into clinical trial reporting

A study commissioned by the Association of the British Pharmaceutical Industry (ABPI) was published this week in the journal Current Medical Research and Opinion. It suggests that there is now greater transparency for industry-sponsored clinical trials. This would be good. We are asking the ABPI about the methodology, the exclusion of incomplete trials from the […]

14th November 2013|